Lv1
100 积分 2025-03-26 加入
Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
17小时前
已完结
Target and tissue selectivity of PROTAC degraders
17天前
已完结
Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation
19天前
已完结
The Efficacy of Pemigatinib in Advanced NSCLC With FGFR Aberration: Case Report
23天前
已完结
Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules
25天前
已完结
Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex
1个月前
已完结
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design
1个月前
已完结
Emerging roles of cyclin-dependent kinase 7 in health and diseases
1个月前
已完结
Targeting CDK7 in oncology: The avenue forward
1个月前
已完结
Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges
1个月前
已完结
皖公网安备34019202002308
